They wrote off $500M of China revenue, cancelled $450M in backlog, and still guided gross margins up to 62%.
Thesis: KLA is successfully swapping empty calories (China volume) for protein (Leading Edge intensity). The street sees the $500M export control hit as a growth cap; the data shows it's a mix shift toward higher-margin, higher-intensity N2/HBM nodes where KLA has a monopoly on yield. They are guiding to outgrow WFE while severing their biggest volume market. That is structural dominance.
Verdict: LONG — Conviction: HIGH
Catalyst: Investor Day confirmation of the new N2/HBM intensity model, explicitly linking the +100-150bps uplift to long-term revenue targets.
Key Risk: TSMC N2 ramp delay. The entire growth bridge depends on N2/HBM intensity filling the China hole. If the node slips, the bridge collapses.
The Tell: CFO Higgins admitting RPO was down $900M and explicitly attributing half of it ($450M) to 'de-bookings we took due to the December 2nd regulations.' Most CFOs would bury this in a net number or blame 'timing.' He highlighted the exact regulatory evaporation.
Friction Level: MODERATE_FRICTION — The China math. Bears see a $500M hole and regulatory risk. Bulls see an intensity inflection at N2/HBM that overpowers the volume loss.
Report not found
The report data is no longer available. Please return to the archive.